Cargando…
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants
PURPOSE: Pregnant women have unprecedented choices for prenatal screening and testing. Cell-free DNA (cfDNA) offers the option to screen for aneuploidy of all chromosomes and genome-wide copy-number variants (CNVs), expanding screening beyond the common trisomies (“traditional” cfDNA). We sought to...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257487/ https://www.ncbi.nlm.nih.gov/pubmed/33731879 http://dx.doi.org/10.1038/s41436-021-01135-8 |